Melatonin sensitizes human malignant glioma cells against TRAIL-induced cell death

被引：55

作者：

Martin, Vanesa ^{[1
]}

Garcia-Santos, Guillermo

Rodriguez-Blanco, Jezabel

Casado-Zapico, Sara

Sanchez-Sanchez, Ana

Antolin, Isaac

Medina, Maria ^{[2
,3
]}

Rodriguez, Carmen

机构：

[1] Fac Med, Dept Morfol & Biol Celular, Oviedo 33006, Spain

[2] Univ Oviedo, Fac Med, Area Fisioterapia, Dept Cirugia, Oviedo, Spain

[3] Hosp Jove, Serv Rehabil, Principado De Asturias, Spain

来源：

CANCER LETTERS | 2010年 / 287卷 / 02期

关键词：

Melatonin; Glioma; TRAIL; Apoptosis; Death receptors; FACTOR-RELATED APOPTOSIS; TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; CENTRAL-NERVOUS-SYSTEM; PROSTATE-CANCER CELLS; BCL-2; OVEREXPRESSION; IONIZING-RADIATION; BREAST-CANCER; IN-VITRO; INHIBITION;

D O I：

10.1016/j.canlet.2009.06.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Despite the common expression of death receptors, many types of cancer including gliomas are resistant to the death receptor ligand (TRAIL). Melatonin antitumoral actions have been extensively described, including oncostatic properties on several tumor types and improvement of chemotherapeutic regimens. Here, we found that melatonin effectively increase cell sensitivity to TRAIL-induced cell apoptosis in A172 and U87 human glioma cells. The effect seems to be related to a modulation of PKC activity which in turns decreases Akt activation leading to an increase in death receptor 5 (DR5) levels and a decrease in the antiapoptotic proteins survivin and bcl-2 levels. (C) 2009 Elsevier Ireland Ltd. All rights reserved.

引用

页码：216 / 223

页数：8

共 50 条

[21] Quercetin sensitizes human myeloid leukemia KG-1 cells against TRAIL-induced apoptosis
Naimi, Adel
Entezari, Atefeh
Hagh, Majid Farshdousti
Hassanzadeh, Ali
Saraei, Raedeh
Solali, Saeed
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 13233 - 13241
[22] Hypoxia sensitizes human malignant glioma cells towards CD95L-induced cell death
Steinbach, JP
Wolburg, H
Klumpp, A
Weller, M
JOURNAL OF NEUROCHEMISTRY, 2005, 92 (06) : 1340 - 1349
[23] Hypoxia sensitizes human malignant glioma cells toward CD95L-induced cell death
Steinbach, J
Wolburg, H
Klumpp, A
Weller, M
NEURO-ONCOLOGY, 2005, 7 (03) : 300 - 300
[24] Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
Chen, Zhiyu
Sangwan, Veena
Banerjee, Sulagna
Chugh, Rohit
Dudeja, Vikas
Vickers, Selwyn M.
Saluja, Ashok K.
CANCER LETTERS, 2014, 348 (1-2) : 156 - 166
[25] SALIRASIB INDUCES APOPTOSIS AND SENSITIZES HEPATOCARCINOMA CELL LINES TO DOXORUBICIN AND TRAIL-INDUCED CELL DEATH
Charette, Nicolas
De Saeger, Christine
Horsmans, Yves J.
Leclercq, Isabelle A.
Starkel, Peter
HEPATOLOGY, 2010, 52 (04) : 955A - 955A
[26] Reduction of TRAIL-induced McI-1 and cIAP2 by c-Myc or sorafenib sensitizes resistant human cancer cells to TRAIL-induced death
Ricci, M. Stacey
Kim, Seok-Hyun
Ogi, Kazuhiro
Plastaras, John P.
Ling, Jianhua
Wang, Wenge
Jin, Zhaoyu
Liu, Yingqiu Y.
Dicker, David T.
Chiao, Paul J.
Flaherty, Keith T.
Smith, Charles D.
Ei-Deiry, Wafik S.
CANCER CELL, 2007, 12 (01) : 66 - 80
[27] Survivin downregulation by siRNA sensitizes human hepatoma cells to TRAIL-induced apoptosis
Nakao, Kazuhiko
Hamasaki, Keisuke
Ichikawa, Tatsuki
Arima, Kazuhiko
Eguchi, Katsumi
Ishii, Nobuko
ONCOLOGY REPORTS, 2006, 16 (02) : 389 - 392
[28] EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-induced apoptosis
Siddiqui, Imtiaz A.
Malik, Arshi
Adhami, Vaqar M.
Mukhtar, Hasan
CANCER RESEARCH, 2006, 66 (08)
[29] Andrographolide sensitizes human renal carcinoma cells to TRAIL-induced apoptosis through upregulation of death receptor 4
Bi, Ran
Deng, Yuyou
Tang, Chao
Xuan, Lei
Xu, Bo
Du, Yujun
Wang, Chunxi
Wei, Wei
ONCOLOGY REPORTS, 2020, 44 (05) : 1939 - 1948
[30] Luteolin sensitizes human 786-O renal cell carcinoma cells to TRAIL-induced apoptosis
Ou, Yen-Chuan
Li, Jian-Ri
Kuan, Yu-Hsiang
Raung, Shue-Ling
Wang, Chung-Chiang
Hung, Yu-Yeh
Pan, Pin-Ho
Lu, Hsi-Chi
Chen, Chun-Jung
LIFE SCIENCES, 2014, 100 (02) : 110 - 117

← 1 2 3 4 5 →